Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2012 Jun 29;49(5):409–416. doi: 10.1007/s13312-012-0077-6

Case Reports

Ira Shah 1,2,✉, Maria Pia De Carolis 3,5,✉, Silvia Salvi 4, Iliana Bersani 3, Sara De Carolis 4, M Sanklecha 6,7,✉, N Mehta 6, H Bagban 6, Binitha Rajeswari 8,✉, Anu Ninan 8, Sindhu Nair Prasannakumari 9, Kusumakumary Parukuttyamma 8
PMCID: PMC7096863  PMID: 22700667

The content is available as a PDF (481.3 KB).

Contributor Information

Ira Shah, Email: irashah@pediatriconcall.com.

Maria Pia De Carolis, Email: mpia.decarolis@rm.unicatt.it.

M. Sanklecha, Email: doctormukesh@gmail.com

Binitha Rajeswari, Email: rbinitha@yahoo.co.in.

References

  • 1.Gershburg E., Pagano J.S. Epstein-Barr virus infections: prospects for treatment. J Antimicrob Chemo. 2005;56:277–281. doi: 10.1093/jac/dki240. [DOI] [PubMed] [Google Scholar]
  • 2.Pagano J.S., Blaser M., Buendia M.A., Damania B., Khalili K., Raab-Traub N., et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004;14:453–471. doi: 10.1016/j.semcancer.2004.06.009. [DOI] [PubMed] [Google Scholar]
  • 3.Pagano J.S. Epstein-Barr Virus and the Infectious Mononucleosis Syndrome. In: Humes H.D., Dupont H.L., editors. Kelley’s Textbook of Internal Medicine. 4th edn. Philadelphia.: Lippincott-Raven Publishers; 2000. pp. 2181–2185. [Google Scholar]
  • 4.Righetti E., Ballon G., Ometto L., Cattelan A.M., Menin C., Zanchetta M., et al. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy. AIDS. 2002;16:63–73. doi: 10.1097/00002030-200201040-00009. [DOI] [PubMed] [Google Scholar]
  • 5.Vezina H.E., Balfour H.H., Jr, Weller D.R., Anderson B.J., Brundage R.C. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis. J Clin Pharmacol. 2010;50:734–742. doi: 10.1177/0091270009351884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Balfour H.H., Jr, Hokanson K.M., Schacherer R.M., Fietzer C.M., Schmeling D.O., Holman C.J., et al. A virologic pilot study of valacyclovir in infectious mononucleosis. J Clin Virol. 2007;39:16–21. doi: 10.1016/j.jcv.2007.02.002. [DOI] [PubMed] [Google Scholar]
  • 7.Nadal D., Leverger G., Sokal E.M., Floret D., Perel Y., Leibundgut K., et al. An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children. J Infect Dis. 2002;186:S123–S130. doi: 10.1086/342968. [DOI] [PubMed] [Google Scholar]
  • 8.Özçay F., Arslan H., Bilezikçi B., Sevmis S., Moray G., Haberal M. The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients. Transplant Proc. 2009;41:2878–2880. doi: 10.1016/j.transproceed.2009.07.059. [DOI] [PubMed] [Google Scholar]
  • 9.Carvalho A.P., Gandolfi L.V., Tonelli E. Epstein-Barr virus infection in children with AIDS. J Pediatr. 1998;74:125–134. doi: 10.2223/jped.423. [DOI] [PubMed] [Google Scholar]
  • 10.Academic Health Center at the University of Minnesota. Antiviral drug effective for treatment of Infectious mononucleosis may also reduce person-to-person spread. Available at URL http://www.ahc.umn.edu//news/releases/monol121905/home.html. Accessed on February 09, 2007.

References

  • 1.Boffa M.C., Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus. 2007;16:634–641. doi: 10.1177/0961203307079039. [DOI] [PubMed] [Google Scholar]
  • 2.Contractor S., Hiatt M., Kosmin M., Kim H.C. Neonatal thrombosis with anticardiolipin antibody in baby and mother. Am J Perinatol. 1992;9:409–410. doi: 10.1055/s-2007-999276. [DOI] [PubMed] [Google Scholar]
  • 3.Hage M.L., Liu R., Marcheschi D.G., Bowie J.D., Allen N.B., Macìk B.G. Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report. Prenat Diagn. 1994;14:873–877. doi: 10.1002/pd.1970140918. [DOI] [PubMed] [Google Scholar]
  • 4.Tabbutt S., Griswold W.R., Ogino M.T., Mendoza A.E., Allen J.B., Reznik V.M. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. J Perinatol. 1994;14:66–70. [PubMed] [Google Scholar]
  • 5.deVeber G., Andrew M., Adams C., Bjornson B., Booth F., Buckley D.J., et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417–423. doi: 10.1056/NEJM200108093450604. [DOI] [PubMed] [Google Scholar]
  • 6.Ramenghi L.A., Govaert P., Fumagalli M., Bassi L., Mosca F. Neonatal cerebral sinovenous thrombosis. Semin Fetal Neonatal Med. 2009;14:278–283. doi: 10.1016/j.siny.2009.07.010. [DOI] [PubMed] [Google Scholar]
  • 7.Motta M., Rodriguez-Perez C., Tincani A., Lojacono A., Nacinovich R., Chirico G. Neonates born from mothers with autoimmune disorders. Early Human Development. 2009;85:S67–S70. doi: 10.1016/j.earlhumdev.2009.08.020. [DOI] [PubMed] [Google Scholar]
  • 8.Meroni P.L., Borghi M.O., Raschi E., Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011;7:330–339. doi: 10.1038/nrrheum.2011.52. [DOI] [PubMed] [Google Scholar]
  • 9.Boffa M.C., Lachassinne E., Boinot C., De Carolis S., Rovere-Querini P., Avcin T., et al. European registry of babies born to mothers with antiphospholipid syndrome. A result update. Lupus. 2009;18:900–904. doi: 10.1177/0961203309106951. [DOI] [PubMed] [Google Scholar]

References

  • 1.Loser H., Schmid K., Wilfing A., Winkler S., Staudinger T., Kletzmayr J., et al. Experiences with severe P. falciparum malaria in the intensive care unit. Intensive Care Med. Intensive Care Med. 2000;26:195–201. doi: 10.1007/s001340050045. [DOI] [PubMed] [Google Scholar]
  • 2.Gachot B., Wolff M., Nissack G., Veber B., Vachon F. Acute lung injury complicating imported Plasmodium falciparum malaria. Chest. 1995;108:746–749. doi: 10.1378/chest.108.3.746. [DOI] [PubMed] [Google Scholar]
  • 3.Hamada A., Watanabe N., Tanaka H., Kobayashi A. Falciparum malaria with bone marrow abnormalities resembling malignant histiocytosis. Trans R Soc Trop Med Hyg. 1989;83:331. doi: 10.1016/0035-9203(89)90490-2. [DOI] [PubMed] [Google Scholar]
  • 4.Rowe A.K., Rowe S.Y., Snow R.W. The burden of malaria mortality among African children in the year. Int J Epidemiol. 2000;35:691–704. doi: 10.1093/ije/dyl027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Taylor W.R., Cañon V., White N.J. Pulmonary manifestations of malaria: recognition and management. Treat Respir Med. 2006;5:419–428. doi: 10.2165/00151829-200605060-00007. [DOI] [PubMed] [Google Scholar]
  • 6.Ohno T., Shirasaka A., Sugiyamma T., Furukawa H. Hemophagocytic syndrome induced by Plasmodium falciparum malaria infection. Int J Hematol. 1996;64:263–266. doi: 10.1016/0925-5710(96)00495-1. [DOI] [PubMed] [Google Scholar]
  • 7.Sermet-Gaudelus I., Abadie V., Stambouli F., Hennequin C., Lenoir G., Gendrel D. Haemophagocytic syndrome in Plasmodium falciparum malaria. Acta Pediatr. 2000;89:368–369. doi: 10.1111/j.1651-2227.2000.tb01343.x. [DOI] [PubMed] [Google Scholar]
  • 8.Aouba A., Noguera M.E., Clauvel J.P., Quint L. Hemophagocytic syndrome associated with plasmodium vivax infection. Br J Haematol. 2000;103:832–833. doi: 10.1046/j.1365-2141.2000.01968.x. [DOI] [PubMed] [Google Scholar]
  • 9.Zvulunov A., Tamary H., Gal N. Pancytopenia resulting from hemophagocytosis in malaria. Pediatr Infect Dis J. 2002;21:1086–1088. doi: 10.1097/00006454-200211000-00028. [DOI] [PubMed] [Google Scholar]

References

  • 1.Mano Y., Yokoyama K., Chen C.K., Tsukada Y., Ikeda Y., Okamoto S. Acute myeloid leukemia presenting with obstructive jaundice and granulocytic sarcoma of the common bile duct. Rinsho Ketsueki. 2004;45:1039–1043. [PubMed] [Google Scholar]
  • 2.Rajesh G., Sadasivan S., Hiran K.R., Nandakumar R., Balakrishnan V. Acute myeloid leukemia presenting as obstructive jaundice. Indian J Gastroenterol. 2006;25:93–94. [PubMed] [Google Scholar]
  • 3.Jaing T.H., Yang C.P., Chang K.W., Wang C.J., Chiu C.H., Luo C.C. Extrahepatic obstruction of the biliary tract as the presenting feature of acute myeloid leukemia. J Pediatr Gastroenterol Nutr. 2001;33:620–622. doi: 10.1097/00005176-200111000-00022. [DOI] [PubMed] [Google Scholar]
  • 4.Lee J.Y., Lee W.S., Jung M.K., Jeon S.W., Cho C.M., Tak W.Y., et al. Acute myeloid leukemia presenting as obstructive jaundice caused by granulocytic sarcoma. Gut Liver. 2007;1:182–185. doi: 10.5009/gnl.2007.1.2.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Matsueda K., Yamamoto H., Doi I. An autopsy case of granulocytic sarcoma of the porta hepatis causing obstructive jaundice. J Gastroenterol. 1998;33:428–433. doi: 10.1007/s005350050108. [DOI] [PubMed] [Google Scholar]
  • 6.King D.J., Ewen S.W.B., Sewell H.F., Dawson A.A. Obstructive jaundice-An unusual presentation of granulocytic sarcoma. Cancer. 2006;60:114–117. doi: 10.1002/1097-0142(19870701)60:1<114::AID-CNCR2820600121>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  • 7.Gonzales-vela M.C., Val-bernal J.F., Mayorga M., Cagigal M.L., Fernandez F., Mazzora F. Myeloid sarcoma of the extrahepatic bile ducts presenting as obstructive jaundice. APMIS. 2006;114:666–668. doi: 10.1111/j.1600-0463.2006.apm_491.x. [DOI] [PubMed] [Google Scholar]
  • 8.Sung C.O., Ko Y.H., Park C.K., Jang K.T., Heo J.C. Isolated biliary granulocytic sarcoma followed by acute myelogeneous leukemia with multilineage dysplasia: A case report and literature review. J Korean Med Sci. 2006;21:550–554. doi: 10.3346/jkms.2006.21.3.550. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Pediatrics are provided here courtesy of Nature Publishing Group

RESOURCES